Literature DB >> 35771425

Evaluation of Pharmaceutical Inhibition of Vasculogenic Mimicry In Vitro.

Joseph C Manarang1, Alison McDermott2.   

Abstract

Vasculogenic mimicry formation is generally assessed using three-dimensional (3D) cultures of aggressive tumor cells grown over an extended incubation period. Test agents can be introduced during growth of the 3D cultures to determine their effect on vasculogenic mimicry formation. Here, we describe the protocol for evaluation of the inhibitory effect of drugs on vasculogenic mimicry in vitro using bright-field and fluorescence microscopy on 3D cultures of tumor cells grown in Matrigel.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  3D matrix; Chamber slides; Fluorescence microscopy; Matrigel; Tube formation assay; Vasculogenic mimicry

Mesh：

Substances：

Year:  2022        PMID： 35771425     DOI： 10.1007/978-1-0716-2403-6_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


  19 in total

1.  Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft.

Authors:  Kazuo Shirakawa; Hisataka Kobayashi; Yuji Heike; Satomi Kawamoto; Martin W Brechbiel; Fujio Kasumi; Toshihiko Iwanaga; Fumio Konishi; Masaaki Terada; Hiro Wakasugi
Journal:  Cancer Res       Date:  2002-01-15       Impact factor: 12.701

2.  Long non-coding RNA MALAT1 promotes gastric cancer tumorigenicity and metastasis by regulating vasculogenic mimicry and angiogenesis.

Authors:  Yue Li; Zhenzhen Wu; Jia Yuan; Li Sun; Li Lin; Na Huang; Jianping Bin; Yulin Liao; Wangjun Liao
Journal:  Cancer Lett       Date:  2017-03-06       Impact factor: 8.679

Review 3.  Vasculogenic mimicry.

Authors:  Robert Folberg; Andrew J Maniotis
Journal:  APMIS       Date:  2004 Jul-Aug       Impact factor: 3.205

4.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.

Authors:  A J Maniotis; R Folberg; A Hess; E A Seftor; L M Gardner; J Pe'er; J M Trent; P S Meltzer; M J Hendrix
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

5.  Induction of Vasculogenic Mimicry Overrides VEGF-A Silencing and Enriches Stem-like Cancer Cells in Melanoma.

Authors:  Caroline I Schnegg; Moon Hee Yang; Subrata K Ghosh; Mei-Yu Hsu
Journal:  Cancer Res       Date:  2015-03-13       Impact factor: 12.701

6.  Hsp90β promotes aggressive vasculogenic mimicry via epithelial-mesenchymal transition in hepatocellular carcinoma.

Authors:  Jing Meng; Shuang Chen; Yue-Yang Lei; Jing-Xia Han; Wei-Long Zhong; Xiao-Rui Wang; Yan-Rong Liu; Wan-Feng Gao; Qiang Zhang; Qiang Tan; Hui-Juan Liu; Hong-Gang Zhou; Tao Sun; Cheng Yang
Journal:  Oncogene       Date:  2018-08-07       Impact factor: 9.867

7.  CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia.

Authors:  Xing-Gang Mao; Xiao-Yan Xue; Liang Wang; Xiang Zhang; Ming Yan; Yan-Yang Tu; Wei Lin; Xiao-Fan Jiang; Hong-Gang Ren; Wei Zhang; Shao-Jun Song
Journal:  Neuro Oncol       Date:  2013-05-03       Impact factor: 12.300

8.  Hypoxia-induced vasculogenic mimicry formation in human colorectal cancer cells: Involvement of HIF-1a, Claudin-4, and E-cadherin and Vimentin.

Authors:  Wen Li; ShaoQi Zong; Qi Shi; HongJia Li; Jian Xu; Fenggang Hou
Journal:  Sci Rep       Date:  2016-11-21       Impact factor: 4.379

9.  Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers.

Authors:  Simona Camorani; Elvira Crescenzi; Matteo Gramanzini; Monica Fedele; Antonella Zannetti; Laura Cerchia
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

10.  Circular RNA circ_HIPK3 is down-regulated and suppresses cell proliferation, migration and invasion in osteosarcoma.

Authors:  Ma Xiao-Long; Zhu Kun-Peng; Zhang Chun-Lin
Journal:  J Cancer       Date:  2018-04-26       Impact factor: 4.207
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.